Olema Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (OLMA)

CUSIP: 68062P106

Q3 2025 13F Holders as of 30 Sep 2025

Security type / class
Equity / Common Stock, $0.0001 par value per share
Total 13F shares
68,238,531
Total 13F value
$668,036,044
Holder snapshot 6 visible 7 signals
Share change
-2,487,156
Put/Call ratio
3.4%
SEC-reported price per share
$9.79
Number of holders
124
Value change
-$3,229,086
Number of buys
60
Open additional details 1 more signal available
Number of sells
51
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
91,696,172

Security key

68062P106

Report period

Q3 2025

Institutions

124

Top holders

10

OLMA full security history Ownership snapshot Full 13F holder table Newer quarter: Q4 2025 Previous quarter: Q2 2025 Olema Pharmaceuticals, Inc. SEC filings Olema Pharmaceuticals, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of OLMA - Olema Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Paradigm Biocapital Advis...
Disclosed value leader
Paradigm Biocapital Advis...
Comparable rows
15/15
Latest evidence
30 Jun 2025
3/4/5 13D/G 13F Lead comparable stake: 10% 13D/G row: Paradigm Biocapital Advisors LP Showing 1-6 of 15 holder rows.

Quick read

Paradigm Biocapital Advisors LP leads the comparable SEC ownership view at 10%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Paradigm Biocapital Advisors LP's linked filing trail.
Comparable ownership Top 5
Paradigm Biocapital Advisors LP 10%
Logos Global Management LP 4.7%
Point72 Asset Management, L.P. 2.3%
Bain Capital Life Sciences Invest... 7.5%
BVF INC/IL 5.8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Paradigm Biocapital Advisors LP
3/4/5 13D/G 13F
10%+ Owner · Company
3/4/5 13D/G 13F
10%
from 13D/G
$173,767,954
13,407,200 shares
 — 01 Aug 2024
Logos Global Management LP
13D/G 13F
Company
13D/G 13F
4.7%
$16,172,730
3,208,875 shares
 $0 18 Mar 2025
Point72 Asset Management, L.P.
13D/G
13D/G
2.3%
$7,781,412
1,543,931 shares
 $0 31 Mar 2025
Bain Capital Life Sciences Investors, LLC
13F 3/4/5
Company · 10%+ Owner
13F 3/4/5
7.5%
$29,155,244
6,843,954 shares
 — 30 Jun 2025
BVF INC/IL
13F
Company
13F
5.8%
$22,560,504
5,295,893 shares
 — 30 Jun 2025
BlackRock, Inc.
13F
Company
13F
5%
$19,617,764
4,605,109 shares
 — 30 Jun 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
124
Shares
68,238,531
Rows available
124
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders
120
Q3 2025 holders
124
Holder diff
4
Investor Q2 2025 Shares Q3 2025 Shares Share Diff Share Chg % Q2 2025 value Q3 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .